Lynley V. Marshall

4.9k total citations
62 papers, 1.2k citations indexed

About

Lynley V. Marshall is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lynley V. Marshall has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Oncology and 20 papers in Genetics. Recurrent topics in Lynley V. Marshall's work include Glioma Diagnosis and Treatment (20 papers), Neuroblastoma Research and Treatments (19 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). Lynley V. Marshall is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Neuroblastoma Research and Treatments (19 papers) and Childhood Cancer Survivors' Quality of Life (10 papers). Lynley V. Marshall collaborates with scholars based in United Kingdom, France and Spain. Lynley V. Marshall's co-authors include Andrew D.J. Pearson, Birgit Geoerger, Gilles Vassal, Darren Hargrave, Chris Jones, Paul Workman, Marta Viana‐Pereira, Nathalie Gaspar, Lucas Moreno and Suzanne E. Little and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Lynley V. Marshall

53 papers receiving 1.2k citations

Peers

Countries citing papers authored by Lynley V. Marshall

Since Specialization

Citations

This map shows the geographic impact of Lynley V. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynley V. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynley V. Marshall more than expected).

Fields of papers citing papers by Lynley V. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynley V. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynley V. Marshall. The network helps show where Lynley V. Marshall may publish in the future.

Co-authorship network of co-authors of Lynley V. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Lynley V. Marshall. A scholar is included among the top collaborators of Lynley V. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynley V. Marshall. Lynley V. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study 2025 ·Targeted Oncology ·(unknown), Lynley V. Marshall, François Doz, Jaume Català‐Mora, Kevin Bielamowicz, Nadège Corradini, Anne‐Marie Langevin, Aru Narendran, Amy Smith, C. Michel Zwaan, (unknown), (unknown), Stephen C. Fowler, (unknown), (unknown), (unknown), Ronald J. Bernardi, Tanya Trippett, (unknown)	0
2	LGG-47. VINBLASTINE TO PREVENT TUMOUR REBOUND AFTER BEVACIZUMAB/IRINOTECAN IN CHILDREN AND ADOLESCENTS WITH MULTIPLY RELAPSED LOW-GRADE GLIOMAS: THE SOUTH LONDON PAEDIATRIC & TYA NEURO-ONCOLOGY NETWORK EXPERIENCE 2024 ·Neuro-Oncology ·(unknown), Julia Cockle, Paola Angelini, Elwira Szychot, (unknown), Henry Mandeville, Sucheta Vaidya, Lynley V. Marshall, Fernando Carceller	0
3	DIPG-53. AN EXCEPTIONALLY RARE CASE OF A DIFFUSE MIDLINE GLIOMA WITH CONCOMITANT H3.1 K27M AND G34R MUTATIONS IN THEHIST1H3C (H3C3) GENE 2024 ·Neuro-Oncology ·Zita Reisz, Rita Pereira, (unknown), Alan Mackay, Leena Bhaw, Yura Grabovska, Ross C. Laxton, Valeria Molinari, Anna Burford, Barnaby Clark, (unknown), Bassel Zebian, (unknown), Fernando Carceller, Lynley V. Marshall, Andrew King, István Bódi, Safa Al‐Sarraj, Chris Jones, Matthew Clarke	0
4	Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART 2024 ·European Journal of Cancer ·Birgit Geoerger, Francisco Bautista, Nicolás André, Pablo Berlanga, Susanne A. Gatz, Lynley V. Marshall, (unknown), (unknown), Antonin Marchais, (unknown), Stéphane Ducassou, C. Michel Zwaan, Michela Casanova, Karsten Nysom, (unknown), Natalie Hoog-Labouret, Agnès Buzyn, P. Blanc, Xavier Paolettí, Gilles Vassal	3
5	716TiP DETERMINE: A pioneering UK precision medicine trial for rare cancers 2023 ·Annals of Oncology ·Gary Middleton, Lynley V. Marshall, Lucinda Billingham, Kate Duffus, Alastair Greystoke, Louise Carter, Martin Förster, Natalie Cook, Darren Hargrave, Sarah Danson, Patricia Roxburgh, Andrew D. Beggs, Anshuman Chaturvedi, Louis Chesler, (unknown), Caroline Dive, Dominic G. Rothwell, Jacqui Gath, Sarah Halford, Matthew Krebs	1
6	Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial 2023 ·European Journal of Cancer ·Birgit Geoerger, Lynley V. Marshall, Karsten Nysom, Guy Makin, Éric Bouffet, Anne Sophie Defachelles, Loredana Amoroso, Isabelle Aerts, Pierre Leblond, Paulette Barahona, (unknown), Eric Fu, Flavio Solca, Robert M. Lorence, David S. Ziegler	3
7	Growing wiser with age: Results from the ACCELERATE Fostering Age Inclusive Research Group clinical trial survey. 2023 ·Journal of Clinical Oncology ·(unknown), (unknown), Maud Toulmonde, (unknown), (unknown), Christina Bucci‐Rechtweg, Gianluca Rossato, Martin Elliott, Mark W. Kieran, Stergios Zacharoulis, Solange Corriol‐Rohou, Lynley V. Marshall, Nathalie Gaspar	1
8	Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab 2023 ·Nature Cancer ·Arash Nabbi, Arnavaz Danesh, Osvaldo Espin‐Garcia, (unknown), (unknown), (unknown), Joseph N. Paulson, Birgit Geoerger, Lynley V. Marshall, Tanya Trippett, Gianluca Rossato, Trevor J. Pugh, Katherine E. Hutchinson	5
9	A phase 1b study of crizotinib in combination with temsirolimus in pediatric ALK- or MET-aberrated relapsed or refractory neuroblastoma (ITCC-053): Results of the phase 1 part. 2023 ·Journal of Clinical Oncology ·(unknown), Reineke A. Schoot, Natasha K. A. van Eijkelenburg, Alwin D. R. Huitema, Michela Casanova, Dirk Reinhardt, Lynley V. Marshall, Isabelle Aerts, Giuseppe Barone, Louis Chesler, (unknown), Debbie Hughes, (unknown), Lucas Moreno, Pauline Winkler-Seinstra, Keith D. Wilner, C. Michel Zwaan, Jasper van der Lugt	1
10	Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations 2022 ·Frontiers in Pediatrics ·(unknown), Lynley V. Marshall, Fernando Carceller, Louis Chesler, Michael Hubank, Sally L. George	3
11	Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma 2021 ·European Journal of Cancer ·Ananth Shankar, Tom Kurzawinski, Emma Ross, Sara Stoneham, Tim Beale, Ian Proctor, (unknown), Kate Simpson, Mark N. Gaze, (unknown), Evelien Gevers, Lynley V. Marshall, Johnathan Hubbard, Caroline Brain	14
12	Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors 2021 ·Frontiers in Oncology ·Jason Fangusaro, Maria Giuseppina Cefalo, Maria Luisa Garrè, Lynley V. Marshall, Maura Massimino, (unknown), (unknown), Jennifer Poon, (unknown), (unknown), (unknown), Mathew Simcock, (unknown), Darren Hargrave, François Doz, Katherine E. Warren	6
13	First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial 2021 ·European Journal of Cancer ·Raphael J. Morscher, (unknown), Pablo Berlanga, Lynley V. Marshall, Nicolás André, (unknown), Isabelle Aerts, Émilie De Carli, Nadège Corradini, (unknown), Xavier Paolettí, Peter G. Mortimer, Ludovic Lacroix, Gaëlle Pierron, Gudrun Schleiermacher, Gilles Vassal, Birgit Geoerger	24
14	Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma 2020 ·Journal of Experimental & Clinical Cancer Research ·Sally L. George, Virinder S. Parmar, Federica Lorenzi, Lynley V. Marshall, Yann Jamin, Evon Poon, Paola Angelini, Louis Chesler	37
15	Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial 2019 ·The Lancet Oncology ·Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, Lynley V. Marshall, Catherine Vézina, Alberto S. Pappo, Theodore W. Laetsch, Antônio Sérgio Petrilli, Martin Ebinger, Jacek Toporski, Julia Glade Bender, Wayne Nicholls, Elizabeth Fox, Steven G. DuBois, Margaret E. Macy, Susan L. Cohn, Kumudu Pathiraja, Scott J. Diede, Scot Ebbinghaus, Navin Pinto	208
16	Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study 2015 ·European Radiology ·Keiko Miyazaki, Neil P. Jerome, David J. Collins, Matthew Orton, James A. d’Arcy, Toni Wallace, Lucas Moreno, Andrew D.J. Pearson, Lynley V. Marshall, Fernando Carceller, Martin O. Leach, Stergios Zacharoulis, Dow‐Mu Koh	17
17	A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study 2014 ·Clinical Cancer Research ·Lucas Moreno, Lynley V. Marshall, Andrew D.J. Pearson, Bruce Morland, Martin Elliott, Quentin Campbell‐Hewson, Guy Makin, Sarah Halford, Gary D Acton, Philip Ross, (unknown), Victoria Lock, Ana Isabel Enríquez Rodríguez, John F. Lyons, Alan V. Boddy, (unknown), Murray Yule, Darren Hargrave	39
18	Lactate and Choline Metabolites Detected In Vitro by Nuclear Magnetic Resonance Spectroscopy Are Potential Metabolic Biomarkers for PI3K Inhibition in Pediatric Glioblastoma 2014 ·PLoS ONE ·Nada M.S. Al-Saffar, Lynley V. Marshall, L. Elizabeth Jackson, (unknown), Thomas R. Eykyn, Alice Agliano, Paul A. Clarke, Chris Jones, Paul Workman, Andrew D.J. Pearson, Martin O. Leach	25
19	EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines 2009 ·Clinical Cancer Research ·Dorine A. Bax, Nathalie Gaspar, Suzanne E. Little, Lynley V. Marshall, Lara Perryman, Marie Regairaz, Marta Viana‐Pereira, Raisa Vuononvirta, Swee Y. Sharp, Jorge S. Reis‐Filho, João N. Stávale, Safa Al‐Sarraj, Rui Manuel Reis, Gilles Vassal, Andrew D.J. Pearson, Darren Hargrave, David W. Ellison, Paul Workman, Chris Jones	71
20	Defibrotide in the prevention and treatment of veno‐occlusive disease in autologous and allogeneic stem cell transplantation in children 2008 ·Pediatric Blood & Cancer ·Amrana Qureshi, Lynley V. Marshall, Donna Lancaster	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact